Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Translational Stroke Research
Published in: Translational Stroke Research 6/2018

01-12-2018 | Editorial

An Update On Medical Treatment for Intracerebral Hemorrhage

Authors: Xiang Li, Dongxia Feng, Gang Chen

Published in: Translational Stroke Research | Issue 6/2018

Login to get access

Excerpt

Intracerebral hemorrhage (ICH), as a kind of hemorrhage stroke, is characterized by high morbidity, mortality, and disability rates, which is a most serious disease in neurosurgery [1, 2]. There are about 2 million new cases of ICH around the world every year, and the incidence is as high as 20~30% in Asia, which is a serious threat to human health [3]. ICH is caused by the rupture of blood vessels, and blood flows into the surrounding brain parenchyma. As the global population ages, the incidence of ICH is predicted to increase. Therefore, understanding the pathogenesis of ICH and identification of novel targets are helpful to researchers for developing new drugs for ICH therapy. The aim of this editorial is to summarize the development of preclinical and clinical medical treatments for ICH. …
Literature
1.
2.
Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11(8):720–31.CrossRefPubMed
3.
Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355–69.CrossRefPubMed
4.
Bodmer D, Vaughan KA, Zacharia BE, Hickman ZL, Connolly ES. The molecular mechanisms that promote edema after intracerebral hemorrhage. Transl Stroke Res. 2012;3(Suppl 1):52–61.CrossRefPubMed
5.
Williamson MR, Colbourne F. Evidence for decreased brain parenchymal volume after large intracerebral hemorrhages: a potential mechanism limiting intracranial pressure rises. Transl Stroke Res. 2017;8(4):386–96.CrossRefPubMedPubMedCentral
6.
Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365(9457):387–97.CrossRefPubMed
7.
Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013;382(9890):397–408.CrossRefPubMedPubMedCentral
8.
Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355–65.CrossRefPubMed
9.
Butcher KS, Jeerakathil T, Hill M, Demchuk AM, Dowlatshahi D, Coutts SB, et al. The intracerebral hemorrhage acutely decreasing arterial pressure trial. Stroke. 2013;44(3):620–6.CrossRefPubMed
10.
Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375(11):1033–43.CrossRefPubMedPubMedCentral
11.
Wilkinson DA, Pandey AS, Thompson BG, Keep RF, Hua Y, Xi G. Injury mechanisms in acute intracerebral hemorrhage. Neuropharmacology. 2018;134(Pt B):240–8.CrossRefPubMed
12.
Sprigg N, Flaherty K, Appleton JP, Al-Shahi Salman R, Bereczki D, Beridze M, et al. Tranexamic acid for hyperacute primary intracerebral haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. 2018;391(10135):2107–15.CrossRefPubMedPubMedCentral
13.
Dang G, Yang Y, Wu G, Hua Y, Keep RF, Xi G. Early erythrolysis in the hematoma after experimental intracerebral hemorrhage. Transl Stroke Res. 2017;8(2):174–82.CrossRefPubMed
14.
Xiong XY, Wang J, Qian ZM, Yang QW. Iron and intracerebral hemorrhage: from mechanism to translation. Transl Stroke Res. 2014;5(4):429–41.CrossRefPubMed
15.
Hatakeyama T, Okauchi M, Hua Y, Keep RF, Xi G. Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats. Transl Stroke Res. 2013;4(5):546–53.CrossRefPubMed
16.
Sun YM, Wang YT, Jiang L, Xue MZ. The effects of deferoxamine on inhibition for microglia activation and protection of secondary nerve injury after intracerebral hemorrhage in rats. Pak J Pharm Sci. 2016;29(3 Suppl):1087–93.PubMed
17.
Ni W, Okauchi M, Hatakeyama T, Gu Y, Keep RF, Xi G, et al. Deferoxamine reduces intracerebral hemorrhage-induced white matter damage in aged rats. Exp Neurol. 2015;272:128–34.CrossRefPubMedPubMedCentral
18.
Xie Q, Gu Y, Hua Y, Liu W, Keep RF, Xi G. Deferoxamine attenuates white matter injury in a piglet intracerebral hemorrhage model. Stroke. 2014;45(1):290–2.CrossRefPubMed
19.
Gu Y, Hua Y, Keep RF, Morgenstern LB, Xi G. Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets. Stroke. 2009;40(6):2241–3.CrossRefPubMedPubMedCentral
20.
Zheng M, Du H, Ni W, Koch LG, Britton SL, Keep RF, et al. Iron-induced necrotic brain cell death in rats with different aerobic capacity. Transl Stroke Res. 2015;6(3):215–23.CrossRefPubMedPubMedCentral
21.
Lule, S., L. Wu, L.M. McAllister, W.J. Edmiston, 3rd, J.Y. Chung, E. Levy, et al., Genetic inhibition of receptor interacting protein kinase-1 reduces cell death and improves functional outcome after intracerebral hemorrhage in mice. Stroke, 2017. 48(9):2549–2556.CrossRefPubMed
22.
Selim M. Deferoxamine mesylate: a new hope for intracerebral hemorrhage: from bench to clinical trials. Stroke. 2009;40(3 Suppl):S90–1.CrossRefPubMed
23.
Huang FP, Xi G, Keep RF, Hua Y, Nemoianu A, Hoff JT. Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg. 2002;96(2):287–93.CrossRefPubMed
24.
Donovan FM, Pike CJ, Cotman CW, Cunningham DD. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci. 1997;17(14):5316–26.CrossRefPubMed
25.
Xi G, Reiser G, Keep RF. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J Neurochem. 2003;84(1):3–9.CrossRefPubMed
26.
Zhou Y, Wang Y, Wang J, Anne Stetler R, Yang QW. Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol. 2014;115:25–44.CrossRefPubMed
27.
Hamada R, Matsuoka H. Antithrombin therapy for intracerebral hemorrhage. Stroke. 2000;31(3):794–5.CrossRefPubMed
28.
Lee KR, Kawai N, Kim S, Sagher O, Hoff JT. Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J Neurosurg. 1997;86(2):272–8.CrossRefPubMed
29.
Wang Z, Zhou F, Dou Y, Tian X, Liu C, Li H, et al. Melatonin alleviates intracerebral hemorrhage-induced secondary brain injury in rats via suppressing apoptosis, inflammation, oxidative stress, DNA damage, and mitochondria injury. Transl Stroke Res. 2018;9(1):74–91.CrossRefPubMed
30.
Duan X, Wen Z, Shen H, Shen M, Chen G. Intracerebral hemorrhage, oxidative stress, and antioxidant therapy. Oxidative Med Cell Longev. 2016;2016:1203285.CrossRef
31.
Zhou F, Chen G, Zhang J. Edaravone reduces brain oedema and attenuates cell death after intracerebral haemorrhage in mice. Brain Inj. 2009;23(4):353–7.CrossRefPubMed
32.
Zeng J, Chen Y, Ding R, Feng L, Fu Z, Yang S, et al. Isoliquiritigenin alleviates early brain injury after experimental intracerebral hemorrhage via suppressing ROS- and/or NF-kappaB-mediated NLRP3 inflammasome activation by promoting Nrf2 antioxidant pathway. J Neuroinflammation. 2017;14(1):119.CrossRefPubMedPubMedCentral
33.
Chiu CD, Chiu YP, Lin CL, Ji HR, Shen CC, Lee HT, et al. Acetazolamide alleviates sequelae of hyperglycemic intracerebral hemorrhage by suppressing astrocytic reactive oxygen species. Free Radic Res. 2018:1–11.
34.
Lyden PD, Shuaib A, Lees KR, Davalos A, Davis SM, Diener HC, et al. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT trial. Stroke. 2007;38(8):2262–9.CrossRefPubMed
35.
Xu W, Gao L, Li T, Zheng J, Shao A, Zhang J. Mesencephalic astrocyte-derived neurotrophic factor (MANF) protects against neuronal apoptosis via activation of Akt/MDM2/p53 signaling pathway in a rat model of intracerebral hemorrhage. Front Mol Neurosci. 2018;11:176.CrossRefPubMedPubMedCentral
36.
He M, Wang Y, Shen J, Duan C, Lu X, Li J. Bex1 attenuates neuronal apoptosis in rat intracerebral hemorrhage model. Pathol Res Pract. 2018;214(4):527–35.CrossRefPubMed
37.
Schlunk F, Schulz E, Lauer A, Yigitkanli K, Pfeilschifter W, Steinmetz H, et al. Warfarin pretreatment reduces cell death and MMP-9 activity in experimental intracerebral hemorrhage. Transl Stroke Res. 2015;6(2):133–9.CrossRefPubMed
38.
Zhang W, Cui Y, Gao J, Li R, Jiang X, Tian Y, et al. Recombinant osteopontin improves neurological functional recovery and protects against apoptosis via PI3K/Akt/GSK-3beta pathway following intracerebral hemorrhage. Med Sci Monit. 2018;24:1588–96.CrossRefPubMedPubMedCentral
39.
Ayer A, Hwang BY, Appelboom G, Connolly ES Jr. Clinical trials for neuroprotective therapies in intracerebral hemorrhage: a new roadmap from bench to bedside. Transl Stroke Res. 2012;3(4):409–17.CrossRefPubMed
40.
Shen H, Liu C, Zhang D, Yao X, Zhang K, Li H, et al. Role for RIP1 in mediating necroptosis in experimental intracerebral hemorrhage model both in vivo and in vitro. Cell Death Dis. 2017;8(3):e2641.CrossRefPubMedPubMedCentral
41.
Zille M, Karuppagounder SS, Chen Y, Gough PJ, Bertin J, Finger J, et al. Neuronal death after hemorrhagic stroke in vitro and in vivo shares features of ferroptosis and necroptosis. Stroke. 2017;48(4):1033–43.CrossRefPubMedPubMedCentral
42.
Majmundar N, Kim B, Prestigiacomo CJ. Necroptosis pathway in treatment of intracerebral hemorrhage: novel therapeutic target. World Neurosurg. 2016;89:716–7.CrossRefPubMed
43.
Chang P, Dong W, Zhang M, Wang Z, Wang Y, Wang T, et al. Anti-necroptosis chemical necrostatin-1 can also suppress apoptotic and autophagic pathway to exert neuroprotective effect in mice intracerebral hemorrhage model. J Mol Neurosci. 2014;52(2):242–9.CrossRefPubMed
44.
Li H, Wu J, Shen H, Yao X, Liu C, Pianta S, et al. Autophagy in hemorrhagic stroke: mechanisms and clinical implications. Prog Neurobiol. 2018;163-164:79–97.CrossRefPubMed
45.
Duan XC, Wang W, Feng DX, Yin J, Zuo G, Chen DD, et al. Roles of autophagy and endoplasmic reticulum stress in intracerebral hemorrhage-induced secondary brain injury in rats. CNS Neurosci Ther. 2017;23(7):554–66.CrossRefPubMed
46.
Li H, Liu S, Sun X, Yang J, Yang Z, Shen H, et al. Critical role for Annexin A7 in secondary brain injury mediated by its phosphorylation after experimental intracerebral hemorrhage in rats. Neurobiol Dis. 2018;110:82–92.CrossRefPubMed
47.
Ardizzone TD, Zhan X, Ander BP, Sharp FR. SRC kinase inhibition improves acute outcomes after experimental intracerebral hemorrhage. Stroke. 2007;38(5):1621–5.CrossRefPubMed
48.
Merchant RE, Bullock MR, Carmack CA, Shah AK, Wilner KD, Ko G, et al. A double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury. Ann N Y Acad Sci. 1999;890:42–50.CrossRefPubMed
49.
Armstead, W.M., H. Hekierski, P. Pastor, S. Yarovoi, A.A. Higazi, and D.B. Cines, Release of IL-6 after stroke contributes to impaired cerebral autoregulation and hippocampal neuronal necrosis through NMDA receptor activation and upregulation of ET-1 and JNK. Transl Stroke Res, 2018.
50.
Ren H, Kong Y, Liu Z, Zang D, Yang X, Wood K, et al. Selective NLRP3 (pyrin domain-containing protein 3) inflammasome inhibitor reduces brain injury after intracerebral hemorrhage. Stroke. 2018;49(1):184–92.CrossRefPubMedPubMedCentral
51.
Sheth KN, Rosand J. Targeting the immune system in intracerebral hemorrhage. JAMA Neurol. 2014;71(9):1083–4.CrossRefPubMed
52.
Urday S, Kimberly WT, Beslow LA, Vortmeyer AO, Selim MH, Rosand J, et al. Targeting secondary injury in intracerebral haemorrhage--perihaematomal oedema. Nat Rev Neurol. 2015;11(2):111–22.CrossRefPubMed
53.
Chen S, Yang Q, Chen G, Zhang JH. An update on inflammation in the acute phase of intracerebral hemorrhage. Transl Stroke Res. 2015;6(1):4–8.CrossRefPubMed
54.
Atangana E, Schneider UC, Blecharz K, Magrini S, Wagner J, Nieminen-Kelha M, et al. Intravascular inflammation triggers intracerebral activated microglia and contributes to secondary brain injury after experimental subarachnoid hemorrhage (eSAH). Transl Stroke Res. 2017;8(2):144–56.CrossRefPubMed
55.
Xiong XY, Yang QW. Rethinking the roles of inflammation in the intracerebral hemorrhage. Transl Stroke Res. 2015;6(5):339–41.CrossRefPubMed
56.
Behrouz R. Re-exploring tumor necrosis factor alpha as a target for therapy in intracerebral hemorrhage. Transl Stroke Res. 2016;7(2):93–6.CrossRefPubMed
57.
Zhao X, Sun G, Zhang H, Ting SM, Song S, Gonzales N, et al. Polymorphonuclear neutrophil in brain parenchyma after experimental intracerebral hemorrhage. Transl Stroke Res. 2014;5(5):554–61.CrossRefPubMed
58.
Hammond MD, Ai Y, Sansing LH. Gr1+ macrophages and dendritic cells dominate the inflammatory infiltrate 12 hours after experimental intracerebral hemorrhage. Transl Stroke Res. 2012;3(1):s125–31.CrossRefPubMedPubMedCentral
59.
Park HK, Lee SH, Chu K, Roh JK. Effects of celecoxib on volumes of hematoma and edema in patients with primary intracerebral hemorrhage. J Neurol Sci. 2009;279(1–2):43–6.CrossRefPubMed
60.
Vaughan CJ, Murphy MB, Buckley BM. Statins do more than just lower cholesterol. Lancet. 1996;348(9034):1079–82.CrossRefPubMed
61.
Chen G, Zhang S, Shi J, Ai J, Qi M, Hang C. Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway. Exp Neurol. 2009;216(2):398–406.CrossRefPubMed
62.
Tapia-Perez H, Sanchez-Aguilar M, Torres-Corzo JG, Rodriguez-Leyva I, Gonzalez-Aguirre D, Gordillo-Moscoso A, et al. Use of statins for the treatment of spontaneous intracerebral hemorrhage: results of a pilot study. Cent Eur Neurosurg. 2009;70(1):15–20.CrossRefPubMed
63.
Suzumura A. The role of microglia in neuroinflammation. Brain Nerve. 2017;69(9):975–84.PubMed
64.
65.
Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2006;5(1):53–63.CrossRefPubMed
66.
Wang YC, Wang PF, Fang H, Chen J, Xiong XY, Yang QW. Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury. Stroke. 2013;44(9):2545–52.CrossRefPubMed
67.
Wang YC, Zhou Y, Fang H, Lin S, Wang PF, Xiong RP, et al. Toll-like receptor 2/4 heterodimer mediates inflammatory injury in intracerebral hemorrhage. Ann Neurol. 2014;75(6):876–89.CrossRefPubMed
68.
Kim YS, Kwon JS, Cho YK, Jeong MH, Cho JG, Park JC, et al. Curcumin reduces the cardiac ischemia-reperfusion injury: involvement of the toll-like receptor 2 in cardiomyocytes. J Nutr Biochem. 2012;23(11):1514–23.CrossRefPubMed
69.
Park SJ, Youn HS. Suppression of homodimerization of toll-like receptor 4 by isoliquiritigenin. Phytochemistry. 2010;71(14–15):1736–40.CrossRefPubMed
70.
Wang Z, Wu L, You W, Ji C, Chen G. Melatonin alleviates secondary brain damage and neurobehavioral dysfunction after experimental subarachnoid hemorrhage: possible involvement of TLR4-mediated inflammatory pathway. J Pineal Res. 2013;55(4):399–408.PubMed
71.
Shao Z, Jiao B, Liu T, Cheng Y, Liu H, Liu Y. TAK-242 treatment ameliorates liver ischemia/reperfusion injury by inhibiting TLR4 signaling pathway in a swine model of Maastricht-category-III cardiac death. Biomed Pharmacother. 2016;84:495–501.CrossRefPubMed
72.
Hua F, Tang H, Wang J, Prunty MC, Hua X, Sayeed I, et al. TAK-242, an antagonist for toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice. J Cereb Blood Flow Metab. 2015;35(4):536–42.CrossRefPubMedPubMedCentral
73.
Nakamura M, Shimizu Y, Sato Y, Miyazaki Y, Satoh T, Mizuno M, et al. Toll-like receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in mice. Eur J Pharmacol. 2007;569(3):237–43.CrossRefPubMed
74.
Wang T, Nowrangi D, Yu L, Lu T, Tang J, Han B, et al. Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice. J Neuroinflammation. 2018;15(1):2.CrossRefPubMedPubMedCentral
75.
Mollica L, De Marchis F, Spitaleri A, Dallacosta C, Pennacchini D, Zamai M, et al. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem Biol. 2007;14(4):431–41.CrossRefPubMed
76.
Shin JH, Lee HK, Lee HB, Jin Y, Lee JK. Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain. Neurosci Lett. 2014;558:159–63.CrossRefPubMed
77.
Shen M, Lu J, Dai W, Wang F, Xu L, Chen K, et al. Ethyl pyruvate ameliorates hepatic ischemia-reperfusion injury by inhibiting intrinsic pathway of apoptosis and autophagy. Mediat Inflamm. 2013;461536:2013.
78.
Keep RF, Andjelkovic AV, Xiang J, Stamatovic SM, Antonetti DA, Hua Y, et al. Brain endothelial cell junctions after cerebral hemorrhage: changes, mechanisms and therapeutic targets. J Cereb Blood Flow Metab. 2018;38(8):1255–75.CrossRefPubMed
79.
Liu DZ, Sharp FR. Excitatory and mitogenic signaling in cell death, blood-brain barrier breakdown, and BBB repair after intracerebral hemorrhage. Transl Stroke Res. 2012;3(Suppl 1):62–9.CrossRefPubMed
80.
Wanyong Y, Zefeng T, Xiufeng X, Dawei D, Xiaoyan L, Ying Z, et al. Tempol alleviates intracerebral hemorrhage-induced brain injury possibly by attenuating nitrative stress. Neuroreport. 2015;26(14):842–9.CrossRefPubMed
81.
Xie RX, Li DW, Liu XC, Yang MF, Fang J, Sun BL, et al. Carnosine attenuates brain oxidative stress and apoptosis after intracerebral hemorrhage in rats. Neurochem Res. 2017;42(2):541–51.CrossRefPubMed
82.
Yang Y, Zhang Y, Wang Z, Wang S, Gao M, Xu R, et al. Attenuation of acute phase injury in rat intracranial hemorrhage by cerebrolysin that inhibits brain edema and inflammatory response. Neurochem Res. 2016;41(4):748–57.CrossRefPubMed
83.
Sun Y, Dai M, Wang Y, Wang W, Sun Q, Yang GY, et al. Neuroprotection and sensorimotor functional improvement by curcumin after intracerebral hemorrhage in mice. J Neurotrauma. 2011;28(12):2513–21.CrossRefPubMedPubMedCentral
84.
Chen, H., B. Guan, X. Chen, X. Chen, C. Li, J. Qiu, D. Yang, K.J. Liu, S. Qi, J. Shen, Baicalin attenuates blood-brain barrier disruption and hemorrhagic transformation and improves neurological outcome in ischemic stroke rats with delayed t-PA treatment: involvement of ONOO(−)-MMP-9 pathway. Transl Stroke Res, 2017.
85.
Pang J, Chen Y, Kuai L, Yang P, Peng J, Wu Y, et al. Inhibition of blood-brain barrier disruption by an apolipoprotein E-mimetic peptide ameliorates early brain injury in experimental subarachnoid hemorrhage. Transl Stroke Res. 2017;8(3):257–72.CrossRefPubMed
86.
Liu H, Wang Y, Xiao Y, Hua Z, Cheng J, Jia J. Hydrogen sulfide attenuates tissue plasminogen activator-induced cerebral hemorrhage following experimental stroke. Transl Stroke Res. 2016;7(3):209–19.CrossRefPubMed
87.
Wu B, Ma Q, Khatibi N, Chen W, Sozen T, Cheng O, et al. Ac-YVAD-CMK decreases blood-brain barrier degradation by inhibiting caspase-1 activation of interleukin-1beta in intracerebral hemorrhage mouse model. Transl Stroke Res. 2010;1(1):57–64.CrossRefPubMedPubMedCentral
88.
89.
Shi Y, Zhang L, Pu H, Mao L, Hu X, Jiang X, et al. Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury. Nat Commun. 2016;7:10523.CrossRefPubMedPubMedCentral
90.
Shi Y, Jiang X, Zhang L, Pu H, Hu X, Zhang W, et al. Endothelium-targeted overexpression of heat shock protein 27 ameliorates blood-brain barrier disruption after ischemic brain injury. Proc Natl Acad Sci U S A. 2017;114(7):E1243–52.CrossRefPubMedPubMedCentral
91.
Wang Z, Chen Z, Yang J, Yang Z, Yin J, Zuo G, et al. Identification of two phosphorylation sites essential for annexin A1 in blood-brain barrier protection after experimental intracerebral hemorrhage in rats. J Cereb Blood Flow Metab. 2017;37(7):2509–25.CrossRefPubMed
92.
Rosenberg GA, Navratil M. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology. 1997;48(4):921–6.CrossRefPubMed
93.
Katsu M, Niizuma K, Yoshioka H, Okami N, Sakata H, Chan PH. Hemoglobin-induced oxidative stress contributes to matrix metalloproteinase activation and blood-brain barrier dysfunction in vivo. J Cereb Blood Flow Metab. 2010;30(12):1939–50.CrossRefPubMedPubMedCentral
94.
Lei C, Lin S, Zhang C, Tao W, Dong W, Hao Z, et al. Activation of cerebral recovery by matrix metalloproteinase-9 after intracerebral hemorrhage. Neuroscience. 2013;230:86–93.CrossRefPubMed
95.
Yao Y, Tsirka SE. Chemokines and their receptors in intracerebral hemorrhage. Transl Stroke Res. 2012;3(Suppl 1):70–9.CrossRefPubMed
96.
Dornak, T., M. Kral, Z. Sedlackova, D. Sanak, E. Cechakova, P. Divisova, et al., Predictors for intracranial hemorrhage following intravenous thrombolysis in posterior circulation stroke. Transl Stroke Res, 2018.
97.
Bhatia PM, Chamberlain R, Luo X, Hartley EW, Divani AA. Elevated blood pressure causes larger hematoma in a rat model of intracerebral hemorrhage. Transl Stroke Res. 2012;3(4):428–34.CrossRefPubMed
98.
Jiang B, Li L, Chen Q, Tao Y, Yang L, Zhang B, et al. Role of glibenclamide in brain injury after intracerebral hemorrhage. Transl Stroke Res. 2017;8(2):183–93.CrossRefPubMed
99.
Sukumari-Ramesh S, Alleyne CH Jr, Dhandapani KM. The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) confers acute neuroprotection after intracerebral hemorrhage in mice. Transl Stroke Res. 2016;7(2):141–8.CrossRefPubMed
100.
Yu L, Lu Z, Burchell S, Nowrangi D, Manaenko A, Li X, et al. Adropin preserves the blood-brain barrier through a Notch1/Hes1 pathway after intracerebral hemorrhage in mice. J Neurochem. 2017;143(6):750–60.CrossRefPubMed
101.
Zhao L, Chen S, Sherchan P, Ding Y, Zhao W, Guo Z, et al. Recombinant CTRP9 administration attenuates neuroinflammation via activating adiponectin receptor 1 after intracerebral hemorrhage in mice. J Neuroinflammation. 2018;15(1):215.CrossRefPubMedPubMedCentral
Metadata
Title
An Update On Medical Treatment for Intracerebral Hemorrhage
Authors
Xiang Li
Dongxia Feng
Gang Chen
Publication date
01-12-2018
Publisher
Springer US
Published in
Translational Stroke Research / Issue 6/2018
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI
https://doi.org/10.1007/s12975-018-0664-5

Other articles of this Issue 6/2018

Translational Stroke Research 6/2018 Go to the issue

Original Article

Focal Ischaemic Infarcts Expand Faster in Cerebellar Cortex than Cerebral Cortex in a Mouse Photothrombotic Stroke Model

Author Correction

Author Correction: Predictors for Intracranial Hemorrhage Following Intravenous Thrombolysis in Posterior Circulation Stroke

Original Article

Human Ischaemic Cascade Studies Using SH-SY5Y Cells: a Systematic Review and Meta-Analysis

Original Article

Protein-Energy Malnutrition Exacerbates Stroke-Induced Forelimb Abnormalities and Dampens Neuroinflammation

Original Article

Do the Risk Factors Determine the Severity and Outcome of Cerebral Venous Sinus Thrombosis?

Original Article

ICAM-1null C57BL/6 Mice Are Not Protected from Experimental Ischemic Stroke